A randomized, prospective double-blind comparison of the efficacy of generic propofol (sulphite additive) with Diprivan®

European Journal of Anaesthesiology

Volumn 23, Issue 4, 2006, Pages 341-345

  Olufolabi, A J ^a   Gan, T J ^a   Lacassie, H J ^a   White, W D ^a   Habib, A S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Anaesthetics intravenous, propofol; Anesthesia, general, bispectral index; Drugs generic; Therapeutic equivalency

Indexed keywords

GENERIC DRUG; PROPOFOL; SULFITE;

ABDOMINAL HYSTERECTOMY; ADULT; ANESTHESIA INDUCTION; ANESTHESIA LEVEL; ARTICLE; BISPECTRAL INDEX; BODY WEIGHT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG INFUSION; FEMALE; HUMAN; INTRAVENOUS ANESTHESIA; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL; SURGICAL PATIENT; WHEEZING;

ADULT; DOUBLE-BLIND METHOD; DRUGS, GENERIC; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; PROPOFOL; PROSPECTIVE STUDIES; SULFITES;

EID: 33644791406     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1017/S0265021505001961     Document Type: Article

References (24)

1. DIPRIVAN® (PROPOFOL). Injectable Emulsion Professional Information Brochure, AstraZeneca Pharmaceuticals LP, Wilmington, DE.
2. Patnaik RN, Lesko LJ, Chen ML, Williams RL, and the FDA Individual Bioequivalence Working Group. Individual bioequivalence: new concepts in the statistical assessment of bioequivalence metrics. Clin Pharmacokinet 1997; 33: 1-6.
3. Banahan BF, Kolassa EM. A physician survey on generic drugs and substitution of critical dose medications. Arch Int Med 1997; 157: 2080-2088.
4. Fassoulaki A, Paraskeva A, Papilas K, Patris K. Hypnotic and cardiovascular effects of proprietary and generic propofol formulations do not differ. Can J Anaesth 2001; 48: 459-461.
5. Kayali A, Tuglular I, Ertas M. Pharmacokinetics of carbamazepine. Part I: A new bioequivalency parameter based on a relative bioavailability trial. Eur J Drug Metab Pharmacokinet 1994; 19: 319-325.
6. Shao X, Li H, White PF, Klein KW, Kulstad C, Owens A. Bisulfite-containing propofol: is it a cost-effective alternative to Diprivan for induction of anesthesia? Anesth Analg 2000; 91: 871-875.
7. Ohana E, Sheiner E, Gurman GM. Accidental intra-arterial injection of propofol. Eur J Anaesthesiol 1999; 16: 569-570.
8. Brimacombe J, Gandini D, Bashford L. Transient decrease in arm blood flow following accidental intraarterial injection of propofol into left brachial artery. Anaesth Intens Care 1994; 22: 291-292.
9. Steele H, Cuthrell L. Intra arterial injection of propofol. Anesthesiology 1990; 73: 184-186.
10. Gold WM. Cholinergic pharmacology in asthma. In: Austen KP, Lichtenstein LM, eds. Asthma: Physiology, Immunopharmacology and Treatment. New York, USA: Academic Press, Inc., 1973, 123-162.
11. Maria Y, Vaillant P, Delorme N, Moneret-Vautrin DA. Severe complications related to metabisulfites. Rev Med Interne 1989; 10: 36-40.
12. Quedraogo N, Roux E, Forestier F, Rossetti M, Savineau JP, Marthan R. Effects of intravenous anesthetics on normal and passively sensitized human isolated airway smooth muscle. Anesthesiology 1998; 88: 317-326.
13. Pizov R, Brown RH, Weiss YS et al. Wheezing during induction of general anesthesia with and without asthma: a randomized blinded trial. Anesthesiology 1995; 82: 111-116.
14. Rieschke P, LaFleur BJ, Janicki PK. Effects of EDTA- and sulfite-containing formulations of propofol on respiratory system resistance after tracheal intubation in smokers. Anesthesiology 2003; 98: 323-328.
15. Arain SR, Navani A, Ebert TJ. The effects of thiopental and generic and nongeneric propofol on respiratory resistance during anesthetic induction in patients with reactive airways. J Clin Anesth 2002; 14: 257-261.
16. Mi WD, Sakai T, Singh H, Kudo T, Kudo M, Matsuki A. Hypnotic endpoints vs. the bispectral index, 95% spectral edge frequency and median frequency during propofol infusion with or without fentanyl. Eur J Anaesthesiol 1999; 16: 47-52.
17. Singh H. Bispectral index (BIS) monitoring during propofol-induced sedation and anaesthesia. Eur J Anaesthesiol 1999; 16: 31-36.
18. Leslie K, Sessler DI, Schroeder M, Walters K. Propofol blood concentration and the Bispectral Index predict suppression of learning during propofol/epidural anesthesia in volunteers. Anesth Analg 1995; 81: 1269-1274.
19. Doi M, Gajraj RJ, Mantzaridis H, Kenny GN. Relationship between calculated blood concentration of propofol and electrophysiological variables during emergence from anaesthesia: comparison of bispectral index, spectral edge frequency, median frequency and auditory evoked potential index. Br J Anaesth 1997; 78: 180-184.
20. Ropcke H, Konen-Bergmann M, Cuhls M, Bouillon T, Hoeft A. Propofol and remifentanil pharmacodynamic interaction during orthopedic surgical procedures as measured by effects on bispectral index. J Clin Anesth 2001; 13: 198-207.
21. Pavlin DJ, Coda B, Shen DD et al. Effects of combining propofol and alfentanil on ventilation, analgesia, sedation, and emesis in human volunteers. Anesthesiology 1996; 84: 23-37.
22. Cockshott ID, Briggs LP, Douglas EJ, White M. Pharmacokinetics of propofol in female patients. Br J Anaesth 1987; 59: 1103-1110.
23. Milne SE, Kenny GN, Schraag S. Propofol sparing effect of remifentanil using closed-loop anaesthesia. Br J Anaesth 2003; 90: 623-629.
24. Matot I, Neely CF, Katz RY, Neufeld GR. Pulmonary uptake of propofol in cats. Anesthesiology 1993; 78: 1157-1165.